메뉴 건너뛰기




Volumn 4, Issue 1, 2010, Pages 519-524

Intravitreal injection analysis at the Bascom palmer eye institute: Evaluation of clinical indications for the treatment and incidence rates of endophthalmitis

Author keywords

Endophthalmitis; Intravitreal injections; Vascular targeting agent

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; CEFTAZIDIME; CYCLOPENTOLATE; DEXAMETHASONE; PREDNISOLONE ACETATE; QUINOLONE; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VANCOMYCIN; VASCULOTROPIN ANTIBODY;

EID: 77956100882     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/opth.s11094     Document Type: Article
Times cited : (34)

References (22)
  • 1
    • 58949083350 scopus 로고    scopus 로고
    • Incidence of endophthal mitisrelated to intravitreal injection of bevacizumab and ranibizumab
    • Fintak DR, Gaurav KS, Blinder KJ, et al. Incidence of endophthal mitisrelated to intravitreal injection of bevacizumab and ranibizumab. Retina.2008;28:1395-1399.
    • (2008) Retina , vol.28 , pp. 1395-1399
    • Fintak, D.R.1    Gaurav, K.S.2    Blinder, K.J.3
  • 2
    • 63249134493 scopus 로고    scopus 로고
    • Increased incidence of sterileendophthalmitis after intravitreal triamcinolone acetonide in spring2006
    • Stepien KE, Eaton AM, Jaffe GJ, et al. Increased incidence of sterileendophthalmitis after intravitreal triamcinolone acetonide in spring2006. Retina. 2009;29:207-213.
    • (2009) Retina , vol.29 , pp. 207-213
    • Stepien, K.E.1    Eaton, A.M.2    Jaffe, G.J.3
  • 3
    • 23044505200 scopus 로고    scopus 로고
    • Optical coherencetomography findings after an intravitreal injection of bevacizumab(Avastin) for neovascular age-related macular degeneration
    • Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherencetomography findings after an intravitreal injection of bevacizumab(Avastin) for neovascular age-related macular degeneration. OphthalmicSurg Lasers Imaging. 2005;36:331-335.
    • (2005) OphthalmicSurg Lasers Imaging , vol.36 , pp. 331-335
    • Rosenfeld, P.J.1    Moshfeghi, A.A.2    Puliafito, C.A.3
  • 4
    • 0036161392 scopus 로고    scopus 로고
    • Intravitrealtriamcinolone for the treatment of macular oedema due to central retinalvein occlusion
    • Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitrealtriamcinolone for the treatment of macular oedema due to central retinalvein occlusion. Br J Ophthalmol. 2002;86:247-248.
    • (2002) Br J Ophthalmol , vol.86 , pp. 247-248
    • Greenberg, P.B.1    Martidis, A.2    Rogers, A.H.3    Duker, J.S.4    Reichel, E.5
  • 5
    • 33645641520 scopus 로고    scopus 로고
    • Ranibizumab for treatmentof neovascular age-related macular degeneration: A phase I/II multicenter,controlled, multidose study
    • Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatmentof neovascular age-related macular degeneration: a phase I/II multicenter,controlled, multidose study. Ophthalmology. 2006;113:633-642.
    • (2006) Ophthalmology , vol.113 , pp. 633-642
    • Heier, J.S.1    Antoszyk, A.N.2    Pavan, P.R.3
  • 7
    • 42549140659 scopus 로고    scopus 로고
    • Incidence of acute onsetendophthalmitis following intravitreal bevacizumab (Avastin) injection
    • Mason JO, Milton FW, Feist RM, et al. Incidence of acute onsetendophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina. 2008;28:564-567.
    • (2008) Retina , vol.28 , pp. 564-567
    • Mason, J.O.1    Milton, F.W.2    Feist, R.M.3
  • 8
    • 66049110107 scopus 로고    scopus 로고
    • Endophthalmitis after anti-VEGF injections
    • Klein KS, Walsh MK, Hassan TS, et al. Endophthalmitis after anti-VEGF injections. Ophthalmology. 2009;116:1225.
    • (2009) Ophthalmology , vol.116 , pp. 1225
    • Klein, K.S.1    Walsh, M.K.2    Hassan, T.S.3
  • 9
    • 73349107165 scopus 로고    scopus 로고
    • Risk of endophthalmitisafter intravitreal drug injection when topical antibiotics are not required
    • Bhavsar AR, Googe JM, Stockdale CR, et al. Risk of endophthalmitisafter intravitreal drug injection when topical antibiotics are not required. Arch Ophthalmology. 2009;127:1581-1583.
    • (2009) Arch Ophthalmology , vol.127 , pp. 1581-1583
    • Bhavsar, A.R.1    Googe, J.M.2    Stockdale, C.R.3
  • 10
    • 66349109710 scopus 로고    scopus 로고
    • Pach JM.Infectious endophthalmitis after intravitral injection of antiangiogenicagents
    • Diago T, McCannel CA, Bakri SJ, Pulido JS, Edwards AO, Pach JM.Infectious endophthalmitis after intravitral injection of antiangiogenicagents. Retina. 2009;29:601-60511.
    • (2009) Retina , vol.29 , pp. 601-60511
    • Diago, T.1    McCannel, C.A.2    Bakri, S.J.3    Pulido, J.S.4    Edwards, A.O.5
  • 11
    • 11144239923 scopus 로고    scopus 로고
    • Pegaptanib forneovascular age-related macular degeneration
    • Gragoudas ES, Adamis AP, Cunningham ET, et al. Pegaptanib forneovascular age-related macular degeneration. N Engl J Med. 2004;351:2805-2816.
    • (2004) N Engl J Med , vol.351 , pp. 2805-2816
    • Gragoudas, E.S.1    Adamis, A.P.2    Cunningham, E.T.3
  • 13
    • 68949120403 scopus 로고    scopus 로고
    • Bahcecioglu H.Incidence and management of acute endophthalmitis after intravitrealbevacizumab (Avastin) injection
    • Artunay O, Yuzbasioglu E, Rasier R, Sengül A, Bahcecioglu H.Incidence and management of acute endophthalmitis after intravitrealbevacizumab (Avastin) injection. Eye. 2009;23:2187-2193.
    • (2009) Eye , vol.23 , pp. 2187-2193
    • Artunay, O.1    Yuzbasioglu, E.2    Rasier, R.3    Sengül, A.4
  • 14
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascularage-related macular degeneration
    • Rosenfeld PJ, Brown MD, Heier JS, et al. Ranibizumab for neovascularage-related macular degeneration. N Engl J Med. 2006;355:1419-1431.
    • (2006) N Engl J Med , vol.355 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, M.D.2    Heier, J.S.3
  • 15
    • 33144475205 scopus 로고    scopus 로고
    • Infectious and noninfectiousendophthalmitis after intravitreal high-dosage triamcinoloneacetonide
    • Jonas JB, Kreissing I, Spandau UH, Harder B. Infectious and noninfectiousendophthalmitis after intravitreal high-dosage triamcinoloneacetonide.Am J Ophthalmol. 2006;141:579-580.
    • (2006) Am J Ophthalmol , vol.141 , pp. 579-580
    • Jonas, J.B.1    Kreissing, I.2    Spandau, U.H.3    Harder, B.4
  • 16
    • 49749086517 scopus 로고    scopus 로고
    • Distinguishing between infectious and noninfectiousendophthalmitis after intravitreal triamcinolone injection
    • Roth DB, Flynn HW. Distinguishing between infectious and noninfectiousendophthalmitis after intravitreal triamcinolone injection.Am J Ophthalmol. 2008;146:346-347.
    • (2008) Am J Ophthalmol , vol.146 , pp. 346-347
    • Roth, D.B.1    Flynn, H.W.2
  • 17
    • 0025779878 scopus 로고
    • The Endophthalmitis Vitrectomy Study
    • Doft BH. The Endophthalmitis Vitrectomy Study. Arch Ophthalmol.1991;109:487-489.
    • (1991) Arch Ophthalmol , vol.109 , pp. 487-489
    • Doft, B.H.1
  • 18
    • 42249110488 scopus 로고    scopus 로고
    • Legacy of the Vitrectomy Study
    • Flynn HW, Scott IU. Legacy of the Vitrectomy Study. Arch Ophthalmol.2008;126:559-561.
    • (2008) Arch Ophthalmol , vol.126 , pp. 559-561
    • Flynn, H.W.1    Scott, I.U.2
  • 19
    • 38049186578 scopus 로고    scopus 로고
    • Endophthalmitis after 25-gaugeand 20-gauge pars plana vitrectomy: Incidence and outcomes
    • Scott IU, Flynn HW, Sundeep D, et al. Endophthalmitis after 25-gaugeand 20-gauge pars plana vitrectomy: incidence and outcomes. Retina.2008;28:138-142.
    • (2008) Retina , vol.28 , pp. 138-142
    • Scott, I.U.1    Flynn, H.W.2    Sundeep, D.3
  • 21
    • 0026344747 scopus 로고
    • Prophylaxis of endophthalmitis withpovidone-iodine
    • Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis withpovidone-iodine. Ophthalmology. 1991;98:1769-1775.
    • (1991) Ophthalmology , vol.98 , pp. 1769-1775
    • Speaker, M.G.1    Menikoff, J.A.2
  • 22
    • 34447508448 scopus 로고    scopus 로고
    • The role of topical antibiotic prophylaxis forintravitreal injections
    • Scott IU, Flynn HW. The role of topical antibiotic prophylaxis forintravitreal injections. Arch Ophthalmol. 2007;125:974-976.
    • (2007) Arch Ophthalmol , vol.125 , pp. 974-976
    • Scott, I.U.1    Flynn, H.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.